Podcasts about HIV

The 16th of June marks HIV Awareness Day. At the moment, women in Ireland are facing a rise in HIV diagnoses but public health messaging seems to still be treating them as an afterthought. The Mobile Testing Coordinator at HIV Ireland Ann Piercy joined Sean this afternoon.

“Have some towels…it's gonna get messy!” In this chilling episode of *Predators I've Caught*, Chris examines the case of Deandre Robinson, a certified nursing assistant whose online conversations with someone he believed to be a 15-year old boy led him straight into a law enforcement sting operation. What began as seemingly casual chats quickly escalated into disturbing intentions, exposing a darker side of a man entrusted with caring for others.  As Chris unpacks the investigation step by step, listeners hear how undercover detectives built the case, the evidence that sealed Robinson's fate, and the shocking details of his HIV status that emerged after his arrest.  Sponsored by: OneSkin: Get 15% off OneSkin with the code HANSEN at https://www.oneskin.co/HANSEN  #oneskinpod #ad  Home Title Lock: Go to https://hometitlelock.com/chrishansen and use promo code HANSEN to get a FREE title history report and a FREE TRIAL of their Triple Lock Protection! For details visit https://hometitlelock.com/warranty   AirDoctor: Breathe cleaner air every day with AirDoctor—get up to $300 off at https://AirDoctorPro.com  using promo code HANSEN  TruthFinder.com. To get the answers you're looking for about the new people in your life, and to discover information on potential predators, go to www.TruthFinder.com/predators  Have A Seat merchandise at https://haveaseat.dashery.com/   Learn more about your ad choices. Visit megaphone.fm/adchoices

Type 2 diabetes insulin management (1:30), preexposure prophylaxis for HIV prevention (7:00), blood pressure and obstructive sleep apnea (9:00), metabolic-dysfunction associated steatotic liver disease (11:40), overscreening metabolic-dysfunction associated steatotic liver disease (15:20), appendicitis (17:40), and AFP clinical answers (20:20).

A nonprofit organization is urging folks to know their HIV status, regardless of sexual orientation. Plus, new book urges more people to embrace political activism. Finally, annual music festival celebrates 51 years in Nevada County.

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I'm a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode Introduction Dr. Warrick Bishop, a cardiologist, author, keynote speaker, and CEO of the Healthy Heart Network, hosts this solo episode focused on cardiovascular and general health prevention. Drawing on a recent paper from the University of Chicago, Dr. Bishop explores how primary care physicians can best prioritize preventative interventions to save the most lives. The episode aims to help patients and their loved ones understand which preventative strategies deliver the greatest health benefits. Key Takeaways: A University of Chicago study identified 42 different preventative interventions and ranked them by their ability to reduce mortality and morbidity, highlighting the challenge of covering all of them in a single medical consultation. Pre-exposure prevention for HIV in high-risk individuals ranks as the single most impactful intervention for gaining future life-years, yet it remains significantly underused in primary care settings. Breast cancer reduction medication (anti-estrogen and anti-aromatase drugs) for high-risk individuals ranks second in preventative value, a fact that surprises many, including Dr. Bishop himself. Pre-exposure prevention counseling for intravenous drug use ranks third, requiring primary care physicians to engage in sensitive but critically important conversations. Statin therapy for primary prevention ranks fourth overall and is considered underappreciated and underused, despite strong evidence supporting its benefits. Alcohol counseling and weight loss/dietician referral round out the top six patient-centered interventions, reflecting the ongoing importance of lifestyle modification. When ranked by efficient use of doctor's time rather than pure patient benefit, the list shifts slightly, with hepatitis B screening and hypertension screening entering the top six. For a practical real-world example, a 65-year-old overweight woman would be prioritized for statins, weight loss counseling (potentially including GLP-1 medications), and colorectal cancer screening, followed by reassessment. Not all preventative screenings are equally valuable — cervical screening ranks lower than commonly assumed, while breast cancer risk-reduction medication ranks far higher than most patients or doctors expect. Patients are encouraged to arrive at medical appointments informed and prepared, knowing their personal risk factors so they can make the most of limited consultation time.

Podcast summary of articles from the April 2026 edition of the Journal of Emergency Medicine from the American Academy of Emergency Medicine.  Topics include bystander CPR, Sepsis, Regional Anesthesia under POCUS, Toxicology, Diabetes, and HIV screening.  Guest speaker is Dr. Kinda Sweidan.

This week on Purple Political Breakdown: the guardrails keep getting overridden, and the polls say Americans can feel it. Radell breaks down a president who says an Iran peace deal gets signed any day now while telling you he loves the inflation that same war is causing. A new intelligence chief, Jay Clayton, nominated to clean up the Bill Pulte mess after FISA Section 702 surveillance authority quietly lapsed. Detainees on a hunger and labor strike at Delaney Hall in Newark, and the uncomfortable question of near-free labor for private profit. Then a Breakdown on the gap between what Americans believe is coming, AI risk and democratic decay, and what they will actually act on, including the world's first commercial brain implant and Trump's push to erase his impeachment from the record. Plus a Research on a Dime on the California "rigged election" claims, jungle primaries, and the governor race vote-split. We close on real good news: the ozone layer healing, a twice-yearly shot that stopped HIV in trials, and more. Political Solutions Without Political Bias. Standard Resource Links & Recommendations The following organizations and platforms represent valuable resources for balanced political discourse and democratic participation: PODCAST NETWORK Check Out the Podcast Website: https://www.purplepoliticalbreakdown.com ALIVE Podcast Network: Check out the ALIVE Network where you can catch a lot of great podcasts like my own, led by amazing Black voices. Link: https://alivepodcastnetwork.com/ CONVERSATION PLATFORMS HeadOn: A platform for contentious yet productive conversations. It's a place for hosted and unguided conversations where you can grow a following and enhance your conversations with AI features. Link: https://app.headon.ai/ Living Room Conversations: Building bridges through meaningful dialogue across political divides. Link: https://livingroomconversations.org/ UNITY MOVEMENTS Us United: A movement for unity that challenges Americans to step out of their bubbles and connect across differences. Take the Unity Pledge, join monthly "30 For US" conversation calls, wear purple (the color of unity), and participate in National Unity Day every second Saturday in December. Their programs include the Sheriff Unity Network and Unity Seats at sports events, proving that shared values are stronger than our differences. Link: https://www.us-united.org/ BALANCED NEWS & INFORMATION OtherWeb: An AI-based platform that filters news without paywalls, clickbait, or junk, helping you access diverse, unbiased content. Link: https://otherweb.com/ VOTING REFORM & DEMOCRACY Equal Vote Coalition & STAR Voting: Advocating for voting methods that ensure every vote counts equally, eliminating wasted votes and strategic voting. Link: https://www.equal.vote/star Future is Now Coalition (FiNC): A grassroots movement working to restore democracy through transparency, accountability, and innovative technology while empowering citizens and transforming American political discourse. Link: https://futureis.org/ POLITICAL ENGAGEMENT Independent Center: Resources for independent political thinking and civic engagement. Link: https://www.independentcenter.org/ GET DAILY NEWS Text 844-406-INFO (844-406-4636) with code "purple" to receive quick, unbiased, factual news delivered to your phone every morning via Informed (https://informed.now) Check Out the Unfuck America Tour & National Ground Game: https://www.nationalgroundgame.com/ Check Out the CIVICS App to Know More About Your Politicians: https://www.civicpolitics.com Subscribe to the Substack: https://open.substack.com/pub/purplepoliticalbreakdown ALL LINKS https://linktr.ee/purplepoliticalbreakdown The Purple Political Breakdown is committed to fostering productive political dialogue that transcends partisan divides. We believe in the power of conversation, balanced information, and democratic participation to build a stronger society. Our mission: "Political solutions without political bias." Subscribe, rate, and share if you believe in purple politics, where we find common ground in the middle! Also if you want to be apart of the community and the conversation make sure to Join the Discord: https://discord.gg/ptPAsZtHC9

Decades before Covid-19, the AIDS epidemic tore through communities in the US and around the world. It has killed some 40 million people and continues to take lives today. But early on, research and public policy focused on AIDS as a gay men's disease, overlooking other vulnerable groups—including communities of color and women. This month marks 45 years since the Centers for Disease Control and Prevention published its first report about a mysterious illness that would eventually be called AIDS. So we're bringing back Blindspot: The Plague in the Shadows, from reporters Kai Wright and Lizzy Ratner, which chronicles the first years of the HIV epidemic in New York City. One of the most influential activists for women with AIDS was Katrina Haslip, a prisoner at a maximum-security prison in upstate New York. In the 1980s, Haslip and other incarcerated women started a support group to educate each other about HIV and AIDS.Haslip took her activism beyond prison walls after her release in 1990, even meeting with CDC leaders. One of the main goals was to change the definition of AIDS, which at the time excluded many symptoms that appeared in HIV-positive women. This meant that women with AIDS often did not qualify for government benefits such as Medicaid and disability insurance. The podcast series Blindspot: The Plague in the Shadows is a co-production of The History Channel and WNYC Studios. This is an update of an episode that originally aired in February 2024. Support Reveal's journalism at Revealnews.org/donatenow Subscribe to our weekly newsletter to get the scoop on new episodes at Revealnews.org/newsletter Connect with us on Bluesky, Facebook and Instagram Learn about your ad choices: dovetail.prx.org/ad-choices

Semaglutide Slows Biological Aging A randomized, placebo-controlled study published in Nature Communications found semaglutide slowed biological aging markers by nine percent on the DunedinPACE epigenetic clock in adults living with HIV-associated metabolic disease, with simultaneous improvements across inflammation, heart, kidney, liver, and brain markers. Host Dave Asprey breaks down why this isn't a weight loss story. It's a metabolic inflammation story. He explains why the GLP-1 mechanism hitting insulin signaling, oxidative stress, and inflammatory pathways simultaneously is the real finding, and makes the case that your metabolic markers and your aging markers are the same numbers. Sources: https://www.medicalnewstoday.com/articles/glp-1-drugs-ozempic-wegovy-may-slow-biological-aging https://www.nature.com/articles/s41467-026-72861-3 https://today.ucsd.edu/story/study-popular-glp-1-drug-may-slow-down-biological-aging FDA Approves First New Sunscreen Ingredient in 20 Years The FDA approved bemotrizinol as a permitted OTC sunscreen active ingredient, the first new approval in roughly two decades, clearing it for adults and children six months and older with broad UVA and UVB coverage and low skin absorption. Host Dave Asprey explains why twenty years of regulatory lag left American consumers with inferior chemistry while Europe moved on, why he's watching independent absorption data before updating his own stack, and why consistency of use matters more than perfect formulation when sun protection remains one of the most evidence-backed longevity interventions available. Sources: https://www.fda.gov/news-events/fda-newsroom/press-announcements/fda-expands-sunscreen-options-first-time-20-years https://www.accessdata.fda.gov/scripts/cder/omuf/index.cfm?event=OrderDetail&orderid=OTC000039 https://www.usatoday.com/story/news/health/2026/06/09/new-sunscreen-ingredient-bemotrizinol/90477659007/ Deoxyribose Gel Matches Minoxidil in Hair Regrowth Study Researchers testing a topical gel made from deoxyribose, the sugar backbone of DNA, saw roughly 80 to 90 percent hair regrowth in a mouse model of male-pattern baldness, matching minoxidil results and showing new follicle formation and increased blood vessel activity in treated areas. Host Dave Asprey breaks down why mouse hair regrowth studies have a long history of failing to translate to humans, what a plausible circulation-based mechanism would actually need to show in human trial data before it's worth acting on, and why the molecule itself is interesting enough to keep watching. Sources: https://www.reddit.com/r/Biohackers/comments/1tyt87w/researchers_found_that_a_gel_made_from/ https://www.sciencealert.com/surprise-hair-loss-breakthrough-a-dna-sugar-gel-sparks-robust-regrowth Caffeinated Chewing Gum and Exercise Performance A systematic review and meta-analysis of 21 studies found caffeinated chewing gum produces a small but real ergogenic effect for muscular strength and countermovement jump height, with buccal absorption delivering caffeine faster than capsules or drinks in a five to twenty-five minute pre-training window. Host Dave Asprey breaks down why delivery mechanism is an underrated variable in caffeine optimization, why timing matters as much as dose, and why a modest but measurable edge on a cheap and accessible tool is exactly the kind of practical biohack worth understanding. Sources: https://pubmed.ncbi.nlm.nih.gov/42228847/ https://doi.org/10.1519/JSC.0000000000005530 https://www.reddit.com/r/Biohackers/comments/1u0acgc/fastacting_caffeine_does_caffeinated_chewing_gum/ Vitamin A Overdoses Surge Nearly 40 Percent Medical News Today reported a 38.7 percent spike in vitamin A overdoses in early 2025, driven by online misinformation claiming high-dose vitamin A treats or prevents measles, a claim with no clinical support and real toxicity risk from fat-soluble accumulation in the liver. Host Dave Asprey explains the actual hepatotoxicity and bone demineralization risks of preformed retinol excess, draws the critical distinction between preformed retinol and beta-carotene that got lost in the misinformation cycle, and makes the case that mechanism is not a dosing protocol and confusing the two is how people get hurt. Sources: https://www.medicalnewstoday.com/amp/articles/vitamin-a-overdoses-rose-by-38-7-2025-how-to-get-right-amount World Cup 2026 and Mass Gathering Health Risk With the 2026 FIFA World Cup underway, public health researchers are flagging dense international crowds, high-volume travel, and shared indoor and outdoor spaces as an elevated transmission environment for respiratory illness. Host Dave Asprey reframes the conversation away from germ exposure and toward immune terrain, explains why your resilience going into a high-contact environment is a variable you actually control, and lays out the pre-exposure preparation window that matters most for anyone traveling or attending large events this summer. Sources: https://www.healthline.com/health-news/2026-fifa-world-cup-health-risks-protect-yourself This episode is designed for biohackers, longevity seekers, and high-performance listeners who want mechanism-level clarity on GLP-1 aging biology, sunscreen chemistry and regulatory science, emerging hair regrowth research, caffeine delivery optimization, supplement toxicity risk, and immune terrain preparation for mass gathering events. Host Dave Asprey connects randomized clinical data, epigenetic clock research, consumer health regulation, and real-world optimization protocols into actionable frameworks for extending healthspan, sharpening performance, and staying ahead of the science. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: semaglutide biological aging, GLP-1 epigenetic clock, DunedinPACE aging marker, PCGrimAge mortality risk, bemotrizinol FDA approval, new sunscreen ingredient 2026, UVA UVB broad spectrum sunscreen, deoxyribose hair gel, minoxidil alternative hair regrowth, caffeinated chewing gum performance, buccal caffeine absorption, pre-workout caffeine timing, vitamin A overdose toxicity, preformed retinol hypervitaminosis, fat-soluble vitamin accumulation, World Cup 2026 health risk, immune terrain optimization, mass gathering respiratory illness, biohacking news 2026, longevity research, Dave Asprey, The Human Upgrade Thank you to our sponsors! - Viome | Check it out at viome.com and use code 10DAVE for 10% off. It's time to stop guessing and start knowing your body. - Beyond Wonderland Conference | Oct 13 - 14, 2026. Get your ticket now at wonderlandconference.com. - iRestore | Reverse hair loss at www.irestore.com/DAVE and get exclusive savings on the iRestore Elite, use code DAVE Resources: • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 00:00 – Intro 00:41 – Story 1: Ozempic Slows Aging Clocks 01:53 – Story 2: New Sunscreen Approved 03:12 – Story 3: DNA Sugar & Hair Regrowth 04:38 – Story 4: Caffeine Gum & Performance 06:13 – Story 5: Vitamin A Overdose Spike 07:59 – Story 6: World Cup & Immune Prep 09:34 – Outro See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

We look back on the life of David Hockney - one of the world's most influential modern artists and one of the best-known British contributors to Pop Art. Unlike artists such as Andy Warhol or Roy Lichtenstein, David Hockney's art often focused more on personal experiences, portraits, landscapes and intimate scenes.Also: SpaceX is making its stock market debut in New York, setting Elon Musk on course to be the world's first trillionaire. Iran says major parts of an agreement to end the war with the US have almost been finalised after President Trump claimed a deal was ready to be signed. The UN's top official on HIV and AIDS says massive international aid cuts have left the world's response to the disease "in peril". The number of Palestinians forced from their homes in Occupied East Jerusalem is on the rise. And the American singer Taylor Swift has become the youngest woman ever to be inducted into the prestigious Songwriters Hall of Fame.The Global News Podcast brings you the breaking news you need to hear, as it happens. Listen for the latest headlines and current affairs from around the world. Politics, economics, climate, business, technology, health – we cover it all with expert analysis and insight. Get the news that matters, delivered twice a day on weekdays and daily at weekends, plus special bonus episodes reacting to urgent breaking stories. Follow or subscribe now and never miss a moment. Get in touch: globalpodcast@bbc.co.uk Photo: David Hockney, in front of his own paintings at the Royal Academy's Summer Exhibition in Piccadilly, London in 2004. Credit: Fiona Hanson/PA Wire

BREAKING - TOP NEWS STORIES OF THE WEEK:

Syphilis cases are rising at alarming rates across the American South, especially congenital syphilis, which can be passed from pregnant mothers to their babies. Thomas Dobbs, dean of the John D. Bower School of Population Health at the University of Mississippi, traces the history of syphilis in the United States, from the dramatic declines made possible by antibiotics and public health interventions to the sharp resurgence seen over the last decade. He explains how gaps in prenatal care, rural healthcare deserts, insurance barriers, medication shortages, and the erosion of public health infrastructure have combined to fuel rising infections. particularly among pregnant women and newborns. Later, Joshua O'Neal, program director, Southeast STI/HIV Prevention Training Center, discusses how prevention training centers across the country are helping state health departments and local providers respond to the crisis. O'Neal describes the hands-on work being done to strengthen syphilis prevention and improve access to testing and treatment, like mobile testing programs, provider education, and statewide collaboration efforts. He also shares insights from the “Syphilis in the South” summit, where clinicians, public health leaders, and outreach workers came together to tackle one of the region's most urgent public health challenges.Sustaining Services and Outbreak Response for HIV, Viral Hepatitis, STIs, and TB | ASTHO

The name "Dr. Jonas Salk" is synonymous with one of the greatest public health achievements of all time: The Polio Vaccine. The arrival of Salk's vaccine in 1955 was a beacon of hope and reinforced the role science can play to serve the public good. When asked who owned the patent for the vaccine, Salk famously replied, "There is no patent. Could you patent the sun?" In 1994, and just one year before Dr. Salk passed, polio was considered eliminated in North and South America. Today, vaccine hesitancy - driven by a host of reasons - has eroded childhood immunization rates in some parts of the country, and reignited a debate over vaccines as a stress test for public trust in science.rnrnContinuing the work of Dr. Jonas Salk is his son, Dr. Peter L. Salk. A graduate from Harvard University and Johns Hopkins University School of Medicine, he would go on to work in his father's laboratory at the Salk Institute for Biological Studies from 1972 to 1984, and again from 1991 to 1995. Together, they would research the biology and immunotherapy of cancer and autoimmune diseases, and develop an inactivated vaccine for HIV infection. Nowadays, Dr. Salk spends his time educating the public regarding his father's life and work and exploring approaches to reducing the severity of various public health problems. Since 2009, Dr. Salk has served as president of the Jonas Salk Legacy Foundation in La Jolla, California. He is also an adjunct professor at the University of Pittsburgh's School of Public Health, Department of Infectious Diseases and Microbiology.rnrnIn partnership with the Mt. Sinai Health Foundation, join us as Dr. Peter L. Salk sits down in conversation with Dr. Arthur Lavin, retired pediatrician and Co-Founder of Grandparents for Vaccines. Together, they will discuss the Salk legacy, the state of public trust in science, and the future of public health.

What if a world without HIV wasn't just a dream — but a decision we could make right now? In this compelling episode of Viva La Vulva, Dr. Cara Quant picks up where the conversation left off, diving deep into PrEP — the once-a-day pill (or injectable option) that can reduce the risk of HIV transmission by up to 99%. Yet despite its proven effectiveness, PrEP remains one of the most underutilized prevention tools among the very communities that need it most. For Black women — who are 10 times more likely to receive an HIV diagnosis than their White counterparts — the gap between what's possible and what's accessible is not a medical failure. It's a systemic one. This episode asks the bold question: if the science is there, why aren't the people?The path to a world without HIV runs directly through the communities that have been most left behind — and that means centering Black women's voices, experiences, and bodily autonomy in every part of the conversation. From dismantling the stigma that keeps women from asking their doctors about PrEP, to exposing the structural barriers that make access feel impossible, this episode is equal parts education and empowerment. Because PrEP isn't just a pill — it's a portal to sexual freedom, self-determination, and a future where HIV no longer writes the story of Black women's health. The science exists. The solution exists. Now it's time to make sure every woman who needs it knows she deserves it.

In this episode, the Family Docs Podcast hosts Dr. Rob Assibey and Dr. Cynthia Chen-Joea discuss climate informed patient care and what it means for family physicians in everyday practice. Climate related health impacts are showing up in the exam room through heat related illness, poor air quality, and changing patterns of infectious disease. Dr. Diana Howard and Dr. Alex Sherriffs share what they are seeing in practice and offer practical strategies family physicians can use to better support their patients. They also talk about who is most vulnerable and review a few simple steps physicians can counsel patients about climate related health risks. Guests: Diana Howard, MD, AAHIVS is a Family Medicine and HIV specialist who advocates for inclusive, climate-informed medicine that protects vulnerable communities. As UC San Francisco faculty, she empowers residents to understand how a changing climate impacts primary care. Dr. Howard is a constant advocate for medical trainees' involvement in CAFP activities. Alex Sherriffs, MD, FAAFP is a Family Medicine physician and air quality/climate health advocate who has lived and practiced in California's Central Valley for over 52 years. As UC San Francisco faculty, he integrates climate science into primary care and medical education, focusing on geriatrics, environmental health, prevention, and health equity. Dr. Sherriffs brings regional insight into the health impacts of extreme heat, air pollution, wildfire smoke, and climate-sensitive diseases. Resources: CAFP Online Education: Climate Informed Patient Care education.familydocs.org/climate Climate Change and Health resources available at familydocs.org/climatehealth.  Heat Illness & Vulnerable Populations presentation at 2026 Family Medicine POP!, August 21-23, 2026 in San Diego - familydocs.org/pop  CalEnviroScreen (oehha.ca.gov/calenviroscreen): Identifies populations who are burdened by multiple sources of pollution California Air Districts ww2.arb.ca.gov/california-air-districts Information: This episode of the Family Docs Podcast was supported by the American Board of Family Medicine The Family Docs podcast is developed, produced, and recorded by the California Academy of Family Physicians. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the views or positions of any entities they represent or the California Academy of Family Physicians. More information at www.familydocs.org/podcast.   Visit the California Academy of Family Physicians online at www.familydocs.org.  Follow us on social media: Instagram - https://www.instagram.com/cafp_familydocs   Facebook - https://www.facebook.com/familydocs   LinkedIn - https://www.linkedin.com/company/california-academy-of-family-physicians   

In episode 79 of Going anti-Viral, we represent a panel discussion from June 9, 2026, as part of the IAS–USA Dialogue series Emerging Infections and Health Threats. This Dialogue is a must listen as our distinguished panel of infectious disease experts dives deep into some of the most pressing public health challenges facing the world today. Moderated by Carlos del Rio, MD, a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine, this Dialogue brings together world-class experts Yvonne Maldonado, MD of Stanford University, and Peter Chin-Hong, MD, of the University of California San Francisco. The panel discusses the impact of the World Cup on public health as well as providing updates on current health threats including hantavirus, Ebola, measles, alpha-gal syndrome, and influenza. The panel also provides an update on alpha-gal syndrome and tick-borne diseases, as well as a discussion about an effort by Google to control diseases spread by mosquitoes. Finally, the panelists discuss the risk of the New World screwworm fly to livestock and humans, an outbreak of Campylobacter from the consumption of raw milk, and the impact of the World Cup on influenza in the US.0:00 – Introduction 1:32 – Impact of the World Cup travel on public health7:10 – Lessons learned from the hantavirus outbreak 13:42 – Status of Ebola outbreak, treatment options, and vaccine development25:18 – Update on measles in the US and public health response37:22 – Overview of alpha-gal syndrome and tick-borne diseases42:20 – Update on the Google Debug project45:31 – Risk of the New World screwworm fly to livestock and humans 47:42 – Outbreak of Campylobacter from the consumption of raw milk52:59 – Overview of influenza season in southern hemisphere and risk to the US57:46 – Closing remarks __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Tornadoes strike three states in the Midwest, with more rough weather for other states coming this weekend; More Ohio school districts are struggling with high food costs; A new report finds NY, CA laws restricting PFAS work, but more regulations are needed; A Pennsylvania education summit connects HIV prevention and mental health. 

A single, once-weekly tablet could change HIV treatment landscape; weight loss drug orforglipron efficacy assessed at all stages of menopause; hemophilia treatment Hympavzi gains expanded indication; and the FDA adds a warning label for kidney injury to an over-the-counter weight loss aid.

What if your sex toy belonged on a doctor's shelf? Cynthia, founder of Luxxxe Toys, joins us for a conversation that's equal parts eye-opening and empowering. We dig into why pleasure and sexual wellness aren't just connected; they're inseparable. From the gaps in women's health research to why quality matters for what goes on and in your body, Cynthia keeps it refreshingly real. Plus: AVN, award-winning products, healing after trauma, and the conversation your doctor probably isn't having with you but should be.Use code JORDANDNELLE for a 30% listener discount. Expires July 31, 2026.✨ *Special Offers:* ✨*Splash Blanket!* Use code *Jordan15* to save 15%*ProDx Health* Use *JordanDnelle* to save 25%Thank you to our Sponsors: Splash Blanket, Prodx, PhexxJump to the Good Stuff:05:03 – From real estate to sexual wellness founder07:12 – Why pleasure and wellness are inseparable09:51 – The gaps in women's health research19:50 – AVN recap - what surprised Cynthia most25:15 – The award-winning Jaxon prostate massager30:34 – Luxury vs. budget toys - does it matter?34:10 – Surviving sexual abuse and healing through pleasure37:48 – First-time toy advice for the bedroom40:33 – What Cynthia wants to normalize next43:25 – How do you define pleasure?Pleasure Highlights:Pleasure is a health necessity, not a luxury.Women's bodies are understudied and we deserve better.The right products can support sexual healing.Toys enhance. They don't replace.Your body deserves clean, medical-grade quality.Connect with Cynthia:Instagram @luxx_toys  https://www.instagram.com/luxx_toys/ https://www.luxxxe.com/Enhance your self-awareness by acknowledging and understanding your behavior patterns, and foster a deeper connection with your inner self. Get the Unleashing My Power: A Women's Empowerment and Gratitude Journal to reclaim your power through daily gratitude. Learn more HERE. Connect with Jordan D'Nelle:Facebook @‌jordandnelle Instagram @‌jordandnelle Instagram @‌TheVVVPodcastTikTok @‌jordandnelleYoutube @jordandnellewww.jordandnelle.comEmail: JordanDnelle@VaginasVulvasandVibrators.comLove this Episode?Join the Patreon: patreon.JordanDnelle.comLeave a review on iTunes.Subscribe & Follow on socials!Listen and Subscribe to the Podcast:Apple PodcastsSpotify Podcasts:Youtube @jordandnelle*Disclaimer: This podcast is for informational and/or entertainment purposes only and is not a substitute for medical advice, diagnosis, or treatment. The views and opinions expressed are my own, or those of my guests, and do not necessarily reflect the views of any organizations or institutions with which I am affiliated.Vaginas, Vulvas, and Vibrators — normalizing pleasure, bodies, and sexual health through expert, shame-free conversations.PhexxINDICATIONPhexx® is an on-demand prescription birth control used to prevent pregnancy. Phexx is not effective when used after sex.IMPORTANT SAFETY INFORMATIONRare cases (0.36%) of bladder and kidney infection have been reported. If you have a history of urinary tract problems that keep coming back, you should not use Phexx.Contact your healthcare provider if you are experiencing genitourinary side effects such as vaginal burning, itching, discharge, genital discomfort (including in male partners), yeast infection, urinary tract infection or bacterial vaginosis.Phexx does not protect against any sexually transmitted infections, including HIV. Avoid using Phexx with a vaginal ring.Avoid Phexx if you or your sexual partner is allergic to lactic acid, citric acid, potassium bitartrate, or any of the Ingredients in Phexx. Stop using Phexx If you develop an allergic reaction.For more information about Phexx, talk to your healthcare provider and see full Product Informationat www.phexx.com.Please report side effects by contacting Evofem Biosciences® toll-free at 1-833-EVFMBIO or contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.EVFM-PHX-000068

This week, Marianna sits down with John Faragon to talk about the latest updates to HIV diagnoses, deaths, and prevalence, along with new information on statin use for people with HIV.-- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941)--Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691 

This week, Emily and Perry are coming in hot to discuss the existence of sex, specifically whether or not women have a DSM-5-designated disorder when they don't want it, or if that's a pathology designed to sell women meds. Turns out the data of sexual desire is a complicated and noisy thing to study, but fortunately that's a turn-on for our intrepid hosts. Plus: a diabetes conference gets politicized, losing sleep over getting sleep, and preventative HIV drugs in South Africa. Submit a question for our weekly mailbag at wellnessactually.fm. ParentData survey on sex after kids ParentData episode with Emily Nagoski Buy her book! Previous episodes referenced: What's the deal with testosterone? What's the deal with HRT? What's the deal with peptides?See omnystudio.com/listener for privacy information.

On the showJosh chats to Alan and Aidan from the Brighton Bear Weekend about the fantastic upcoming event.For tickets and more details, follow the link below.https://brightonbearweekend.com/Sue and josh discuss current HIV world and community news.

Two recent studies have shown remarkable advances in HIV cure research: (1) a Norwegian man who achieved long-term HIV remission after a stem cell transplant from his brother and (2) a Phase 1 trial testing CAR-T cell therapy. On this episode, Antonio Urbina, MD, Medical Director for CEI's HIV Primary Care and Prevention Center of Excellence, dives into these studies and puts them into clinical context, including how to discuss cure research with patients. Related Content: CEI Line: 1-866-637-2342  https://ceitraining.org/ Clinicaltrials.gov

We explore why Australia relies on state-based organisations to tackle HIV and sexual health rather than only one national body. Karina Reeves from WAAC and Eleni Gabrielides from Meridian join Joel to discuss how trust, cultural diversity, and geographic isolation demand localised strategies. Chapters 00:00 – Welcome and guest introductions from across Australia 04:53 – Defining health promotion and social determinants of health 07:17 – How HIV sector demographics have changed over time 11:35 – WA and ACT jurisdictional differences and approaches 16:04 – Building trust and community-led health promotion strategies 23:29 – Marketing tensions in community health communication 27:41 – AI, social media and digital era challenges 35:43 – Future projects, funding and exciting upcoming initiatives All chapter timecodes are approximate. Want more Well Well Well? Check out our other JOY Podcasts for more on LGBTIQ+ health and wellbeing at joy.org.au/wellwellwell. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au Find out more about LGBTIQ+ services and events in Victoria and South Australia at thorneharbour.org and samesh.org.au

Every year, tens of millions of people in the U.S. get the flu vaccine. That's because the virus changes year-to-year and protection only lasts around six months. Adolfo Garcia-Sastre wants to change that. He's one scientist working on a universal flu vaccine that could provide decades of protection against all flu illnesses – but only if his team can find the resources that disappeared when U.S. funding dipped.If you liked this episode, listen to our episode on a vaccine trial that could end HIV.Interested in more medical innovations? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy

Benson and Stabler look for a killer who met his victim on an anonymous dating site. They arrest Peter Butler, who's been having quickie sex all over town. The detectives link him to the strangled victim and an unsolved rape, but the physical evidence clears him of those crimes. But they learn Peter is HIV positive and, in a fit of misogyny, has been intentionally infecting women. Cabot charges him with spreading the disease. While on trial, one of his victims sprays acid on his face, leaving him permanently scarred. It's not until Peter's kindly grandfather teaches him a lesson on compassion that he takes responsibility for his actions. We're talking about SVU season 11 episode 11 "Quickie." Our guest from our May 6, 2020 episode is Brandie Posey from the Lady to Lady podcast. This episode is inspired by the real-life case of Nushawn Williams. New episodes of These Are Their Stories will return July 8! For exclusive content from Kevin and Rebecca, sign up on Patreon.This show was recorded in The Caitlin Rogers Project Studio. Click to find out more. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Synopsis: While biotech is increasingly measured by clinical milestones and financial outcomes, Rahul Chaturvedi welcomes two leaders who argue that true success begins and ends with patients. In this deeply personal and inspiring conversation, Mike Raab, President & Chief Executive Officer of Ardelyx, and Laura Williams, Chief Patient Officer, share how empathy, resilience, and patient advocacy have shaped both their careers and the culture of the company they've built. Mike reflects on an unconventional journey that spans pharmaceutical sales, rare disease leadership at Genzyme, venture capital at NEA, and ultimately leading Ardelyx through some of biotech's most difficult challenges—including a Complete Response Letter, massive layoffs, and a historic FDA reversal that resulted in approval without additional clinical trials. Laura shares her path from rural Mississippi to becoming a physician, recounting the transformative patient experience during the HIV epidemic that inspired her move from academia into industry and ultimately into a pioneering Chief Patient Officer role. Together, they explore what patient-centricity truly means beyond corporate slogans, how Ardelyx embedded patient advocacy into the C-suite, and why empathy must be a core competency for biotech leadership. The discussion also dives into clinical trial diversity, commercializing therapies for underserved populations, navigating regulatory adversity, responsible capital allocation, and the future of building enduring biotech companies. It is a powerful reminder that when patients become the North Star, resilience, innovation, and impact naturally follow. Biography: Mike Raab Mike has served as Ardelyx's President and Chief Executive Officer since March 2009. Before Ardelyx, Mike was a partner at New Enterprise Associates (NEA), one of the world's largest and most successful venture capital firms, where he specialized in healthcare investments focusing on the biotechnology and pharmaceutical sectors. Prior to joining NEA in 2002, Mike spent 15 years in commercial and operating leadership roles in the biotech and pharmaceutical industries. He was senior vice president, therapeutics and general manager of the renal division at Genzyme Corporation, a Sanofi company. In this position, Mike launched and oversaw the sales growth of sevelamer, the leading phosphate binder for the treatment of hyperphosphatemia, with over $1.0 billion in worldwide sales in 2013. Mike was also instrumental in the worldwide launch of Genzyme's therapies for Gaucher disease, Ceredase and Cerezyme. Laura Williams, MD, MPH Laura has served as Ardelyx's Chief Patient Officer since 2025, having joined the company in November 2020 as Senior Vice President, Global Therapeutic Strategies and Patient Advocacy. Laura was later promoted to Chief Medical Officer in 2021. Laura is a life science enterprise leader with extensive experience as a pharmaceutical drug developer, healthcare policy advisor, patient advocate, and portfolio strategist. She is an accomplished, results-oriented, physician scientist and board member who is committed to discovering, developing, and commercializing innovative therapies that address unmet medical need. With nearly 30 years of pharmaceutical experience, across all clinical development phases and multiple therapeutic areas, in both large pharma and smaller biotech, Laura has a proven track-record in drug development, as indicated by her leadership and major contributions toward eight drug approvals.

Progressive Graham Platner Vigilance wins Maine Democratic Senate Primary; Trump posts that Iran is "taking too long"; Vigilance is needed by New Mexicans after screwworm crosses the Texas border; New Georgia law expands PrEP, HIV prevention access to pharmacies; and a hearing this week on a California bill to allow plug-in portable solar panels.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The landscape of these industries is one of constant evolution, characterized by scientific advancements, strategic mergers, and regulatory maneuvers that shape the future of healthcare. In a significant scientific breakthrough, Merck & Co. and Gilead Sciences have made strides in HIV treatment with the development of a weekly pill. This innovative regimen combines Merck's islatravir with Gilead's lenacapavir, showing promise in two phase 3 trials. If approved, this long-acting oral therapy could revolutionize HIV care by offering a more convenient dosing schedule, potentially improving patient adherence and outcomes substantially. This novel regimen signifies progress towards simplifying HIV treatments with once-weekly dosing. Meanwhile, in the oncology sector, Gilead's Trodelvy faced challenges when combined with Merck's Keytruda as a first-line treatment for PD-L1-high non-small cell lung cancer. The phase 3 EVOKE-03 trial was terminated, shifting attention to competitors like AstraZeneca and Daiichi Sankyo, who continue to advance their own therapies in this area. In a strategic move to bolster its position in lung cancer treatment, GlaxoSmithKline (GSK) is acquiring Nuvalent for $10.6 billion, aiming to secure near-approval cancer therapies capable of challenging market leaders like Roche and Pfizer. This acquisition underscores the focus on targeted cancer therapies that increase treatment efficacy by honing in on specific genetic markers. Nuvalent's innovative pipeline of small molecule inhibitors targets drug resistance and mutations in cancer treatment—a strategic addition to GSK's portfolio aimed at enhancing its position amidst rapid advancements and intense competition in oncology. In diabetes and obesity management, Eli Lilly is advancing with its new oral GLP-1 receptor agonist, Foundayo (orforglipron), which has shown competitive efficacy over oral semaglutide. Analysts see Lilly's progress as strengthening its leadership in the growing obesity drug market. Similarly, AstraZeneca is making progress with its own GLP-1 candidate, elecoglipron, as phase 2 data sets the stage for pivotal studies. Promising clinical trial data from Eli Lilly's retatrutide for obesity-related conditions and AstraZeneca's elecoglipron suggest a strengthening pipeline for GLP-1 receptor agonists known for their dual effects on weight management and glycemic control. On the diagnostics front, Roche reaffirms its €600 million investment in Germany amid industry retrenchments by companies like Eli Lilly and Boehringer Ingelheim. However, Roche remains cautious about future risks due to shifting economic conditions. The financial dynamics within biotech are also noteworthy. Parabilis Medicines is planning a potentially record-setting IPO following Kailera Therapeutics' successful public offering earlier this year. These trends indicate strong investor confidence and an influx of funding towards innovative cancer therapies. Meanwhile, CeQur's $100 million Series E funding round aims at accelerating insulin patch delivery systems' commercial growth—highlighting ongoing innovation in diabetes management solutions. Regulatory updates reveal AstraZeneca facing reprimands from the UK marketing watchdog due to repeated breaches related to LinkedIn activities—an ongoing challenge in pharmaceutical marketing compliance. The integration of digital health solutions continues apace as ixlayer partners with Vertex Pharmaceuticals to launch a digital acute pain management platform. This initiative aims at improving patient care by reducing reliance on opioid-based treatments. These developments paint a picture of an industry where scientific innovations, regulatory hurdles, and technological advancements intersect to shape future therapeutic landscapes. Precision oncology is another area witnessing substantial growth. The landscape also sees notable activity in rare disease therapeutics. Johnson & Johnson's Talvey has gained acceptance in Scotland for treating relapsed multiple myeloma using bispecific antibody technology—a trend toward leveraging immune system targeting technologies to enhance cancer treatment efficacy. Moreover, Zai Lab's Tivdak received approval from China's NMPA for cervical cancer treatment based on Phase 3 data, highlighting the rise of antibody-drug conjugates (ADCs) as potent oncology therapies due to their targeted delivery mechanisms. On the research collaboration front, AlzeCure Pharma's partnership with Eli Lilly focuses on Alzheimer's disease research through Alzstatin ACD680—a small molecule targeting neurodegenerative pathways—a testament to the collaborative efforts needed to tackle complex diseases like Alzheimer's. However, challenges persist as Bial discontinued its GCase activator program after failing Phase 2b trials for Parkinson's patients with GBA1 variants—a stark reminder of the high-risk nature inherent in drug development despite initial promise. These myriad developments underscore a vibrant period within pharmaceutical and biotech sectors where scientific advancements rapidly translate into actionable therapies promising substantial improvements in patient care by addressing unmet medical needs globally.Support the show

As part of Pride Month, Jonny and Heather conduct interviews with local LGBTQ+ advocates. In the front half of the shaow, Jonny interviews Father Jerry Anderson, author of Ordained by Angels; A Memoir of an AIDS Chaplain. Father Anderson, a native of Southern Illinoi and co-founder of The Episcopal Caring Response to AIDS (ECRA), will be giving a reading from his book at 11:30am this Sunday (June 14th) at the St. Andrews Episcopal Church on Mill Street in Carbondale. He will also be givig the sermon there (referencing Matthew Shepard) at 10am. In the back half of the show, Heather interviews Lindsay Church, a recent independent candidate for US Representative from Illinois District 4. Lindsay Church is a Navy veteran and co-founder of Minority Veterans of America.

U=U is established science, yet many people living with HIV still don't hear the message clearly or consistently from healthcare providers. In this episode, we explore why U=U conversations aren't happening more often in clinical settings, how uncertainty and missed opportunities can affect care, and what role healthcare providers can play in reducing stigma. We also discuss what needs to change to make U=U a routine part of evidence-based HIV care.

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the death of Bulls legend Stacey King, a new study that shows flu medications have the potential to reduce cognitive decline as well as premature aging in people living with HIV, and an experimental vaccine from Moderna […]

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the death of Bulls legend Stacey King, a new study that shows flu medications have the potential to reduce cognitive decline as well as premature aging in people living with HIV, and an experimental vaccine from Moderna […]

With over 30 years of advocacy for the BIPOC LGBTQI+ community, Tandra LaGrone has been on the front lines fighting for equal housing opportunities, access to HIV testing and prevention measures, domestic violence, after-school programs, and so many more vital human rights initiatives. Lavender and Caelan McPherson talk with Tandra LaGrone, executive director of In Our Own Voices to learn more. https://ioov.org/

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the death of Bulls legend Stacey King, a new study that shows flu medications have the potential to reduce cognitive decline as well as premature aging in people living with HIV, and an experimental vaccine from Moderna […]

https://www.patreon.com/highyieldfamilymedicineIntro (0:35),Screening Guidelines (1:46),Syphilis (2:25),Herpes (4:41),Chancroid (6:52),Gonorrhea (7:47),Chlamydia (9:11),Mycoplasma genitalium (11:00),Lymphogranuloma venereum (12:00),Pelvic Inflammatory Disease (13:16),Disseminated Gonococcal Infection (15:23),Trichomoniasis (16:37),Bacterial Vaginosis (18:03),Vulvovaginal Candidiasis (19:43),Human Papillomavirus (21:01),HIV (22:32),PrEP (24:06),Hepatitis B (25:29),Practice Questions (27:18)

Pred 40 leti smo v Sloveniji zabeležili prvi primer AIDS-a, bolezni, ki jo povzroča virus HIV. Bolezen je bila takrat smrtonosna, oseba je umrla hitro, običajno v obdobju od enega do šestih mesecev. Učinkovita zdravila so prišla šele desetletje pozneje, v veliki meri tudi po zaslugi aktivistk in aktivistov. HIV/AIDS je po svetu podiral tabuje in predsodke, saj je bil za preprečitev širjenja okužbe nujen pogovor o spolnosti in drogah. Ljudem je bilo namreč treba razložiti, kako se virus prenaša. Okužba z virusom HIV danes ni več smrtonosna, saj obstajajo učinkovita zdravila in dobra preventiva, kljub temu pa letno po svetu zaradi AIDS-a umre 600 tisoč ljudi. Več kot 40 milijonov ljudi živi z virusom HIV, polovica v podsaharski Afriki. Slovenija je država z najnižjim številom okužb v Evropi in v svetu. V tokratni oddaji Studio ob 17.00 o vsem tem z gosti. Vsebina je bila prvič objavljena v oddaji Intelekta.

Are you actually ready for a committed relationship, or are you just lonely? This Pride Month, Yo Aunteas are joined by elite gay dating coach and matchmaker Lamont White from betterwaytomeet.com to unpack the brutal truths behind the modern dating landscape. If you've been wondering why the dating pool feels impossible to navigate, this conversation is your ultimate reality check. In this episode, we break down why overindulging in hookup culture might be holding you back from finding a husband, how to step away from toxic situationships, and the actual science behind practicing emotional vulnerability. Lamont also shares shocking statistics about dating apps and drops the ultimate first-date playbook (the Voltron blueprint!) that you need to copy right now. Whether you are happily single, actively dating in cities like New York or Atlanta, or navigating long-term relationship agreements, this episode is packed with the relationship advice you've been missing. Tea Stamps: 00:00 — Intro 01:00 — Meet Lamont White: Gay Dating Coach & Matchmaker 03:37 — What are you PROUD of this Pride Month? 06:35 — How Lamont got into dating coaching 10:46 — Hookup culture vs. actually learning to date 12:28 — How to PRACTICE vulnerability 14:09 — Why gay men stay in situationships too long 17:00 — Fear of rejection & loneliness 25:05 — Coaching vs. matchmaking 27:33 — Chemistry vs. anxiety 29:04 — If you don't see him once a week, you are NOT dating 30:01 — Dating while closeted 34:19 — Not everyone is meant to be in a relationship 45:01 — Stop judging other people's relationships 46:35 — Age & dating 49:21 — HIV stigma in dating 53:35 — Love languages 57:48 — Right person, wrong time 59:35 — Work with Lamont White 1:01:05 — Curiositea 1:12:22 — The first date Vultron 1:14:38 — Janet or Beyoncé & benediction   ✨ Support the show, like, comment, and subscribe for more weekly episodes!   Follow our Guest: Website: https://betterwaytomeet.com Social Media: @TheGayDatingCoach   Follow Minoritea Report: Instagram: @MinoriteaReport

Happy Pride Month! Hannah shares the story of the Corpsewood Manor Murders, and Lori covers Oliver “Billy” Sipple, who stopped an assassination attempt on President Gerald Ford. Sheena covers “The Real World” star and HIV activist/educator Pedro Zamora.

Leaked documents expose a white supremacist organization doubling in size every year, now operating in 49 states. Jewish Columbia faculty file antisemitism claims — because they were punished for being the wrong kind of Jewish. Medicaid work requirements could end coverage for people fighting cancer and living with HIV. And Pete Hegseth is reshaping the military in his image — one promotion list at a time. Bishop Joseph Tolton, Founder of Interconnected Justice, brings moral clarity to it all.

TWiV explains research showing limited transmission of cervid prions to nonhuman primates, and the finding that cone-shaped HIV-1 capsids are transported through intact nuclear pores. Hosts: Vincent Racaniello, Alan Dove, and Brianne Barker Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Positions in Rosenfeld Lab (email) Ebola outbreak news (ECDC, WHO) NSF research grants on hold (Nature) Transmission of cervid prions to nonhuman primates (Sci Adv) Cone-shaped HIV-1 capsids transported intact through nuclear pore (Cell) HIV-1 reproduction video (Janet Iwasa) Letters read on TWiV 1329 Timestamps by Jolene Ramsey. Thanks! Picks of the Week Brianne – What We Need to do NEXT Re: OMB Rule Alan – Metallic Realms, by Lincoln Michel Vincent – TWiV 1: West Nile Virus Listener Picks Mark – How the Library of Congress packed 250 years of U.S. history into a vial the size of a quarter Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

Billie is joined by Ashley Habibi — a Latina trans woman, comedian, performer, and person in recovery who is doing a lot, and doing it loudly and proudly during Pride Month.Ashley's story is not a straight line. It winds through a childhood shaped by parental abandonment and being raised by her grandmother in Mexico, through 16 years of performing comedy, through addiction, psychosis, homelessness, and an HIV diagnosis — and then through the moment everything changed: a first date in a wig where strangers stopped her on the street to tell her she was beautiful.She and Billie get into what recovery and transition look like when they happen at the same time, how Ashley became the woman who saved her own life, and what it means to go from having nothing to being an inspiration to others. Plus hormones, electrolysis, broccoli and testosterone, and running for Miss LA Pride 2026.This one's got a lot of heart.

On this episode of The Jon Gordon Podcast, I sit down with Dr. John Gildea—a pioneering researcher on gut health, soil and healing.   Our conversation goes deeper than science, tracing Dr. Gildea's unlikely journey from the lab at the University of Virginia to becoming an integral voice in the movement to restore health through soil-based nutrition. Dr. Gildea shares how his partnership with Dr. Zach Bush set him on the path to groundbreaking discoveries in gut health. Together, we discuss the debilitating personal battle I faced with gut issues for over a decade, and how his research and soil-derived formula became the catalyst for my healing—a story echoed by countless others. Throughout the episode, we unpack the science behind gut barriers, explain how environmental toxins like glyphosate disrupt our health, and reveal why reconnecting to nature's intelligence can help the body heal itself from the inside out. Dr. Gildea demystifies the complex processes at play, explaining the pivotal role of NRF2 and the remarkable results he's witnessed firsthand—even in the most challenging cases. Whether you're struggling with chronic gut issues, curious about the root causes of inflammation, or seeking hope for true health, this conversation is a testament to breakthrough science and the power of nature's solutions. Tune in for an inspiring reminder that healing is possible and that there are answers waiting for those who refuse to give up. To get the ION product that healed my gut and changed my life go here: Gut Support Skin Support Pet Support ION Homepage SAVE 35% ON ION PRODUCTS NOW - SPECIAL OFFER Visit any of the special ION product links above and enter JONGORDON35 at checkout to save 35%   About Dr. Gildea: Dr. John Gildea Chief Science Advisor | ION* Dr. John Gildea is a Johns Hopkins-trained PhD and cellular biologist with more than 60 peer-reviewed publications across 20+ NIH-funded studies. His research career spans early HIV diagnostics, oncology, and foundational work in kidney physiology, with a particular focus on human-derived cell models to study nutrient absorption, cellular signaling, and the body's mechanisms for maintaining internal balance. As Chief Science Advisor at ION*, Dr. Gildea applies that depth of expertise to questions at the intersection of gut barrier integrity, environmental stress, and cellular response — helping translate rigorous science into meaningful insights for human health.   Here's a few additional resources for you… Do you feel called to share your story with the world? Check out Gordon Publishing  Follow me on Instagram: @JonGordon11 Every week, I send out a free Positive Tip newsletter via email. It's advice for your life, work and team. You can sign up now here and catch up on past newsletters. Ready to lead with greater clarity, confidence, and purpose? The Certified Positive Leader Program is for anyone who wants to grow as a leader from the inside out. It's a self-paced experience built around my most impactful leadership principles with tools you can apply right away to improve your mindset, relationships, and results. You'll discover what it really means to lead with positivity… and how to do it every day. Learn more here! Do you feel called to do more? Would you like to impact more people as a leader, writer, speaker, coach and trainer? Get Jon Gordon Certified if you want to be mentored by me and my team to teach my proven frameworks principles, and programs for businesses, sports, education, healthcare!

On September 11, 2001, a gay man living with HIV made a decision that had nothing to do with self-preservation. He ran toward the World Trade Center and spent 24 hours in the pile. Neil Adams met Michael Dorian in New York in the early 1990s and their friendship lasted nearly 30 years. Now he has written the book Michael asked him to write. From the Pile is a debut biography that covers Michael's childhood in poverty, his HIV diagnosis at 16, his life built on compassion, and the choice he made on the worst day in modern American history. This episode is about what it means to show up when it costs you everything. Key Takeaways: Who Michael Dorian was before 9/11 and what shaped his decision to respondWhat it meant for an immunocompromised man to spend 24 hours at Ground ZeroHow a decades-long friendship between two gay men became the foundation of a bookWhat Neil learned about compassion, empathy, and showing up from a man younger than himselfWhy Michael's story was featured in a New York Emmy-winning profile and Spike Lee's 9/11 documentaryWhat this story says about the older gay male community and the conversations we are not having About Neil He knew he was gay, but dated girls, trying to live up to his parents' expectations. Against their wishes, he majored in Drama in college, where he continued to wrestle with his sexuality while staying committed to performing. After graduation, he moved to Los Angeles to pursue acting, knowing he needed to come out in order to be his authentic self. In Los Angeles, he performed in plays and nightclubs and began writing comedy. A job later took him to New York on tour, and he stayed, living the actor's life until he met Michael, which changed everything. After returning to California broke and moving back home, he left acting and went into sales. He later worked in publishing, rising to National Sales Manager before the dot-com bust. From there, he built a career in the special events industry, became active in professional associations, and even won a national singing competition. When he and Michael reconnected later in life, the idea for the book returned. He has now spent 23 years in the events industry, currently working in business development in San Francisco and serving in leadership roles. This is his first book, but definitely not his last. Connect With Neil Website Instagram - Neil's Instagram - The Book Hey Guys, Don't Forget! Join the 40 Plus: Gay Men Gay Talk, monthly chats. - Learn More! Also, join our Facebook Community - 40 Plus: Gay Men, Gay Talk Community

#HIV #우울증 #삶의질성적 다양성과 깊이 맞닿아 있는 HIV 감염증.선진국과 달리, 한국에서는 자신의 정체성도, HIV 감염 사실도 꺼내기 어렵습니다.구직의 벽, 사회적 낙인, 차별 속에서 고립된 HIV 감염인들은자신이 우울하다는 사실조차 알아채지 못한 채 살아갑니다.우울이 깊어지면 약을 거르게 되고,내성이 쉽게 생기는 항바이러스제 특성상 치료도 점점 어려워지는데...우울, 수면 장애, 극단적 선택까지 — 매순간 삶이 위태로운 HIV 감염인들.그들의 삶의 질을 높이기 위해 우리에게 필요한 것은 무엇일까요?순천향대학교 천안병원 감염내과 박정완 교수님, 연세마운틴 정신건강의학과 의원 이산 원장님과 함께비감염인들이 감염인들을 위해 무엇을 할 수 있는지 이야기 나눠봅니다.

The first Gay Games took place in 1982, an inclusive answer to the Olympics. It was a place of activism and community that has grown and changed over the years. Anney and Samantha run down some of the history and performances of the Gay Games, and why it matters.See omnystudio.com/listener for privacy information.

In 2001, Portugal decriminalised the possession and use of all illicit drugs. It was a move designed to mitigate the country's public health crisis, which at the time meant Portugal had one of the worst rates of overdose deaths in Europe, as well as the highest rate of HIV among drug users. Whilst drugs remained illegal, users did not receive a criminal record but were instead referred to rehabilitation and treatment programmes. It was an approach that proved so successful, that it has remained in place for a quarter of a century. But just over 10 years after its introduction, Portugal's drugs policy started to come under strain as the country's economic crisis and subsequent austerity measures led to budget cuts for drug services. More recently the rising cost of living has diverted people's attention from investment in this field. On top of this, the trafficking of cocaine and newer substances into the country along with changing demographics is putting decriminalisation under strain. So, on The Inquiry this week, we're asking ‘Is Portugal's drugs policy in need of reform?' Contributors: Joana Teixeira, President of the Board of Directors, Institute for Addictive Behaviours and Dependencies (ICAD), Lisbon, Portugal Luís Mendão, Director General, Grupo de Ativistas em Tratamentos (GAT), Lisbon, Portugal António Leitão da Silva, Chief of Police, Braga, Portugal Keith Humphreys, Esther Ting Memorial Professor of Psychiatry and Behavioral Sciences at Stanford University, California, USA Presenter: David Baker Producer: Jill Collins Technical Producer: Toby James Editor: Tom Bigwood Production Management: Phoebe Lomas and Liam Morrey(Photo: Discarded drug paraphernalia. Credit: Andy Buchanan/AFP via Getty Images)

Human Immunodeficiency Virus, or HIV, remains one of the most important infectious diseases in modern healthcare, but advances in antiretroviral therapy have transformed it from a fatal diagnosis into a manageable chronic condition for many patients. In this episode, we'll break down the major medication classes used to treat HIV, discuss how these drugs work, review key adverse effects and drug interactions, and highlight practical nursing considerations that impact patient safety and adherence. Whether you work in acute care, outpatient practice, long-term care, or public health, understanding HIV pharmacology is essential to providing compassionate, evidence-based care for patients living with HIV and AIDS. You can find the full 16+ hour nursing pharmacology review course, including PDF handouts, cheat sheets, practice questions, and on-demand videos at meded101.com!

Dr Seth Berkley is an epidemiologist and global health leader whose career has been shaped by one central problem: vaccines save lives, but only if people can actually get them. His 40-year career has spanned the global, from helping to build Uganda's first HIV surveillance system and founding the International AIDS Vaccine Initiative; to leading Gavi, the Vaccine Alliance for more than a decade – overseeing the immunisation of hundreds of millions of children worldwide. And when COVID-19 struck, Seth co-founded COVAX, the global initiative designed to stop wealthy nations monopolising vaccines. In conversation with Professor Jim Al-Khalili, Seth discusses the highs and lows of his globe-trotting career - from saving millions of young lives through vaccine distribution, to setting his own shattered leg after a climbing accident in Namibia - and addresses the huge challenge of tackling vaccine scepticism.